"Merck has implemented a number of initiatives to deter drug counterfeiting in addition to opening rural pharmacies in Africa."
In Conversation
"Tunisia has both, laboratories of innovative MNCs operating in the country as well as local production, solely composed of generics."
"SIPHAT will remain true to its main purpose, being a support institution to the state in its healthcare policies."
"Boukhari Prince Medical has succeeded in finding the right balance between high levels of quality and a competitive rate for its customers."
"We are looking forward to reinforcing our portfolio of products with innovative molecules in promising therapeutic areas or niche markets."
"Concerning the sanitary aspect, the CNSS manages six policlinics in the country as well as an orthopedic equipment center."
"Around 60 percent of Adwya’s turnover comes from licensing agreements the remaining 40 percent stem from generics."
Interview: Ramzi Sandi – General Manager, Arab Society of Pharmaceutical Industries (SAIPH), Tunisia
"SAIPH is a company spread over three regions whose objective was to become a multinational company with an international culture."
"In 2020, the BiotechPole will have successfully opened its Technology Research Center (CRT) that will encompass an operational production line and employees that are perfectly able…
"Our biggest bet to date was putting in place a strategy that would see us become an international company."
"National production is doing well. It represents at least 70 percent of the volume sold on the domestic market."
"Today mc PHARMA’s revenues, including those generated on behalf of our clients, place us as the second largest company in the Tunisian medical promotion field."
